Elevance Health Inc (ELV) Q4 2024 Earnings Call Highlights: Strong EPS and Revenue Growth Amid ...
Elevance Health Inc (ELV) reports robust financial performance with a focus on strategic growth and shareholder returns, despite challenges in Medicaid cost trends.
Elevance Health (ELV) Q4 2024 Earnings Call Transcript
Operator instructions] As a reminder, today's conference is being recorded. I would now like to turn the conference over to the company's management. Please go ahead.Nathan Rich -- Vice President, Investor Relations Good morning,
Elevance Health Q4 2024 Earnings: Managed Care Continues To Impress
Financial writer recommends buying Elevance Health stock despite recent drop, citing strong industry trends and potential for significant upside.
Elevance Health expects to grow MA membership by at least 7% in 2025
Elevance Health posted $418 million in profit for the fourth quarter of 2024, a figure that surpassed Wall Street's expectations despite decreasing 51% year-over-year. | Elevance Health posted $418 million in profit for the fourth quarter of 2024,
Elevance Health Q4 earnings miss estimates, stock rises
The company posted adjusted earnings per share of $3.84 for Q4 2024, falling short of the $3.98 consensus estimate. Revenue came in at $45 billion, slightly above the $44.9 billion analysts had projected and up 6% year-over-year.
Elevance Health Inc. (NYSE:ELV) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript January 23, 2025 Elevance Health Inc. beats earnings expectations. Reported EPS is $3.84, expectations were $3.8. Operator: Ladies and gentlemen, thank you for standing by,
Q4 2024 Elevance Health Inc Earnings Call
Ladies and gentlemen, thank you for standing by, and welcome to the Elevance Health fourth-quarter earnings conference call. (Operator Instructions) As a reminder, today's conference is being recorded. I would now like to turn the conference over to the company's management. Please go ahead.
Elevance Health reports Q4 adjusted EPS $3.84, consensus $3.86
Reports Q4 revenue $45B, consensus $44.72B. “As part of our commitment to elevating whole health and advancing health beyond healthcare, we
Elevance Health Q4 Ad. EPS Miss Market, Revenues Beat; Sees Growth In FY25, Lifts Dividend; Stock Up
Elevance Health Inc. (ELV), while reporting weak fourth-quarter earnings below market estimates, on Thursday issued fiscal 2025 ...
Nasdaq4d
Elevance Health Q4 Countdown: Smart Move to Buy or Stick With Hold?
Elevance Health, Inc. ELV is set to report fourth-quarter 2024 results on Jan. 23, 2024, before the opening bell. The Zacks Consensus Estimate for the to-be-reported quarter’s earnings is ...
Elevance Health Posts Q4 Profit Despite Medicaid Drop, Rising Costs; Hikes Dividend 5%
Elevance Health Q4 revenues hit $45 billion, driven by premium growth and acquisitions. 2025 EPS guidance is $34.15-$34.85, with a $1.71 dividend declared.
Healthcare Finance News1d
Elevance pulls in $418 million in Q4 profit
For the full year, that translated into $175.2 billion in revenue for Elevance (a 2.9% increase over 2023), while profit hit $5.98 billion, almost identical to its total a year ago. Operating revenue ...
Elevance Health price target raised to $512 from $501 at Barclays
Barclays raised the firm’s price target on Elevance Health (ELV) to $512 from $501 and keeps an Overweight rating on the shares post the Q4 ...